arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PULSE BIOSCIENCES, INC.

PLSE
$52.85 ▼ -4.14 (-7.26%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
47 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

PULSE BIOSCIENCES, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.7B
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC -20.1% ↗
FCF / Share $-0.27 ↘
Trailing P/E —
Price / Book 37.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$434.00K
↑ +8.2% —
Net Income Profit after all expenses
$-18.58M
↑ +3.1% —
FCF / Share Free cash flow per share
$-0.27
↓ -26.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑
10
Cash Quality ↓
51

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 12 years · 47 quarters